MISTNASDAQMilestone Pharmaceuticals Inc

MIST price activity

Last Price

Change (24hr)

USD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

MIST price performance

-4,09%

-14,23%

-47,77%

YTD

-38,3%

MIST price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

US-NASDAQ rank

N/A

Sector Rank

N/A

MIST details

View company profile

View company website

View US-NASDAQ Official Page

Dividendos de MIST

Ver mais

quote.marketSignals

Mais formas de descobrir

Ver notícias de United States Descubra sinais de NASDAQ Ver todas as ações de NASDAQ Ver todos os ETFs de NASDAQ

Milestone Pharmaceuticals Inc (US-NASDAQ: MIST)

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Price: $1.06

Sector: Healthcare — Biotechnology